Press-release for stocks related to results for pfe

tags : Results symbols : Pfe

save search

Pfizer Announces Positive Top-Line Results from Phase 3 Study of ABRYSVO® in Adults Aged 18 to 59 at Increased Risk for RSV Disease
Published: 2024-04-09 (Crawled : 12:00) - biospace.com/
PFE | News 4 | $26.27 -0.19% -0.15% 23M

Health Technology

| -0.88% | O: 0.73% H: 2.49% C: 0.11%
abrysvo disease positive risk for rsv results study

Everest Medicines to Announce Full-Year 2023 Financial Results on March 28, 2024
Published: 2024-03-06 (Crawled : 01:00) - prnewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M

Health Technology

| 0.92% | O: 3.14% H: 1.49% C: 1.08%
KZR | $0.8016 -2.95% -3.04% 420K

Health Technology

| -19.42% | O: 1.94% H: 0.0% C: -1.9%
financial results

Arvinas Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
Published: 2024-02-27 (Crawled : 12:00) - globenewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M

Health Technology

| -3.16% | O: -0.22% H: 0.29% C: -0.85%
ARVN | $32.51 -4.38% -4.58% 470K

Health Technology

| -30.31% | O: 0.0% H: 1.25% C: -1.6%
year update financial results

Pfizer Reports Full-Year 2023 Results and Reaffirms Full-Year 2024 Financial Guidance
Published: 2024-01-30 (Crawled : 12:30) - biospace.com/
GNMSF | News | $290.34 3.83% 340

Health Technology

| 5.23% | O: 2.14% H: 1.03% C: -0.89%
ALPMF | News | $9.5 43.47% 1.2K

Health Technology

| -16.3% | O: 1.76% H: 0.0% C: 0.0%
ALPMY | News | $9.49 -1.11% 480K

Manufacturing

| -18.19% | O: -3.53% H: 3.49% C: 3.4%
PFE | News 4 | $26.27 -0.19% -0.15% 23M

Health Technology

| -4.22% | O: 1.49% H: 1.72% C: -3.12%
GMAB | News | $28.47 -0.32% -0.32% 460K

Health Technology

| 0.95% | O: 0.42% H: 0.04% C: -0.99%
ARVN | $32.51 -4.38% -4.58% 470K

Health Technology

| -14.01% | O: -0.46% H: 0.79% C: 0.28%
financial results

Pfizer Announces Topline Phase 2b Results of Oral GLP-1R Agonist, Danuglipron, in Adults with Obesity
Published: 2023-12-01 (Crawled : 22:00) - biospace.com/
PFE | News 4 | $26.27 -0.19% -0.15% 23M

Health Technology

| -13.62% | O: -4.92% H: 1.48% C: -0.21%
obesity topline results

Arvinas Reports Third Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-11-07 (Crawled : 12:00) - globenewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M

Health Technology

| -15.59% | O: -0.32% H: 0.98% C: 0.55%
ARVN | $32.51 -4.38% -4.58% 470K

Health Technology

| 100.83% | O: 1.0% H: 4.2% C: 4.04%
update financial results

BioNTech Announces Third Quarter 2023 Financial Results and Corporate Update
Published: 2023-11-06 (Crawled : 12:00) - globenewswire.com
GNMSF | News | $290.34 3.83% 340

Health Technology

| 0.88% | O: 0.24% H: 3.29% C: -1.11%
SNYNF | News | $94.25 -2.18% 480

Health Technology

| 3.75% | O: 0.16% H: 0.0% C: 0.0%
PFE | News 4 | $26.27 -0.19% -0.15% 23M

Health Technology

| -15.8% | O: 0.19% H: 0.29% C: -0.45%
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| 3.25% | O: 0.21% H: 0.0% C: 0.0%
GMAB | News | $28.47 -0.32% -0.32% 460K

Health Technology

| -1.82% | O: 0.55% H: 0.44% C: -1.37%
BNTX | News | $88.18 -0.35% -0.35% 280K

Health Technology

| -7.61% | O: 5.74% H: 3.18% C: -1.55%
update financial results

Pfizer Reports Third-Quarter 2023 Results
Published: 2023-10-31 (Crawled : 12:00) - biospace.com/
HLNCF | $4.02 -1.48% 200

n/a

| 3.02% | O: 2.0% H: 0.5% C: 0.5%
HLN | $8.35 -0.71% 0.0% 5.2M

n/a

| 4.86% | O: 0.75% H: 0.74% C: 0.12%
AZNCF | News | $140.3 -4.19% 1.5K

Health Technology

| 13.17% | O: 0.73% H: 0.0% C: -1.7%
PFE | News 4 | $26.27 -0.19% -0.15% 23M

Health Technology

| -13.85% | O: -0.87% H: 1.77% C: 0.91%
BNTX | News | $88.18 -0.35% -0.35% 280K

Health Technology

| -5.1% | O: -1.65% H: 2.78% C: 2.0%
AZN | News | $71.175 0.46% 0.46% 6.1M

Health Technology

| 12.57% | O: 0.08% H: 0.41% C: 0.38%
results

Valneva and Pfizer Report Positive Pediatric and Adolescent Phase 2 Booster Results for Lyme Disease Vaccine Candidate
Published: 2023-09-07 (Crawled : 05:00) - globenewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M

Health Technology

| -23.42% | O: 0.29% H: 0.49% C: -0.55%
candidate disease report vaccine positive valneva results phase 2

Everest Medicines Announces Interim Results for First Half of 2023
Published: 2023-08-24 (Crawled : 01:00) - prnewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M

Health Technology

| -28.21% | O: -0.5% H: 0.45% C: -0.86%
GILD | $67.07 0.06% 0.06% 8.3M

Health Technology

| -12.99% | O: 0.27% H: 1.15% C: -1.19%
CALT | $18.5 1.65% 1.62% 1.5K

Health Technology

| 2.25% | O: -4.72% H: 0.0% C: 0.0%
results

Deciphera Pharmaceuticals Announces Second Quarter 2023 Financial Results
Published: 2023-08-09 (Crawled : 13:00) - biospace.com/
PFE | News 4 | $26.27 -0.19% -0.15% 23M

Health Technology

| -26.15% | O: -0.11% H: 1.29% C: 0.67%
INCY | $51.72 0.14% 0.14% 1.5M

Health Technology

| -19.96% | O: 0.08% H: 2.08% C: 1.3%
DCPH | $14.6 -0.48% -0.48% 320K

Health Technology

| 13.37% | O: 4.95% H: 2.5% C: 1.18%
pharmaceuticals financial results

Arvinas Reports Second Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-08-08 (Crawled : 11:00) - globenewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M

Health Technology

| -26.23% | O: 1.93% H: 0.0% C: -2.01%
ARVN | $32.51 -4.38% -4.58% 470K

Health Technology

| 42.74% | O: 1.09% H: 1.29% C: 0.91%
update financial results

Pfizer Reports Second-Quarter 2023 Results
Published: 2023-08-01 (Crawled : 12:00) - biospace.com/
TMO | News | $577.39 0.49% 0.0% 2M

Health Technology

| 1.65% | O: -1.8% H: 0.0% C: 0.0%
PFE | News 4 | $26.27 -0.19% -0.15% 23M

Health Technology

| -27.08% | O: -0.48% H: 0.0% C: 0.0%
BNTX | News | $88.18 -0.35% -0.35% 280K

Health Technology

| -17.6% | O: 1.14% H: 0.0% C: -1.36%
results

Pfizer Announces Positive Marstacimab Results from Pivotal Phase 3 Hemophilia A and B Trial
Published: 2023-05-30 (Crawled : 11:00) - biospace.com/
PFE | News 4 | $26.27 -0.19% -0.15% 23M

Health Technology

| -30.0% | O: -0.64% H: 0.0% C: -0.94%
positive trial results

Pyxis Oncology Reports Financial Results for the First Quarter 2023 and Provides Corporate Update
Published: 2023-05-11 (Crawled : 11:00) - globenewswire.com
PYXS | $4.445 -1.22% -1.24% 230K

Professional, Scientific, and T...

| 51.01% | O: 0.67% H: 6.0% C: 1.33%
PFE | News 4 | $26.27 -0.19% -0.15% 23M

Health Technology

| -31.28% | O: -1.83% H: 0.13% C: -0.05%
update financial results

BioNTech Announces First Quarter 2023 Financial Results and Corporate Update
Published: 2023-05-08 (Crawled : 11:00) - globenewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M

Health Technology

| -31.62% | O: 0.1% H: 0.52% C: 0.36%
SNY | News | $46.66 -2.16% -2.21% 1.7M

Health Technology

| -14.53% | O: 0.59% H: 0.0% C: 0.0%
BNTX | News | $88.18 -0.35% -0.35% 280K

Health Technology

| -18.39% | O: 4.23% H: 0.0% C: -4.4%
update financial results

Arvinas Reports First Quarter 2023 Financial Results and Provides Corporate Update
Published: 2023-05-05 (Crawled : 11:00) - globenewswire.com
PFE | News 4 | $26.27 -0.19% -0.15% 23M

Health Technology

| -31.15% | O: 0.39% H: 0.31% C: 0.29%
ARVN | $32.51 -4.38% -4.58% 470K

Health Technology

| 44.62% | O: 2.04% H: 5.9% C: 5.46%
update financial results

Insmed Reports First Quarter 2023 Financial Results and Provides Business Update
Published: 2023-05-04 (Crawled : 12:20) - biospace.com/
PFE | News 4 | $26.27 -0.19% -0.15% 23M

Health Technology

| -31.55% | O: -0.73% H: 0.68% C: 0.16%
INSM | $25.78 2.02% 1.98% 2.5M

Health Technology

| 27.63% | O: -1.11% H: 3.47% C: -0.1%
business update financial results

Deciphera Pharmaceuticals Announces First Quarter 2023 Financial Results
Published: 2023-05-03 (Crawled : 12:20) - biospace.com/
PFE | News 4 | $26.27 -0.19% -0.15% 23M

Health Technology